The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

From July, eligible Australians will be screened for lung cancer as part of the nation's first new cancer screening program ...

Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...

AstraZeneca and its partner Daiichi Sankyo have won approval from U.S. regulators for their precision drug Datroway to treat ...

Northwestern’s iSeg tool matches expert doctors and finds hidden cancer zones, with clinical rollout expected soon.

Nearly a quarter of all newly-diagnosed patients with advanced lung cancer are not given a test that could improve their chances for long-term survival and reduce their side effects.

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...

Cancer is not a welcome diagnosis, but breakthroughs in genetic sequencing and immunotherapy are making some cancers easier ...

Trained on multi-hospital data, iSeg spots moving tumors doctors sometimes miss, edging radiation treatment toward pinpoint ...

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

With darting red and green beams above me and large mechanical eyes and grids humming and moving around me, I feel as though I’m in a 1950s sci-fi movie.